Uganda plans to test 500,000 people for HIV annually by 2012

NewsGuard 100/100 Score

The Uganda AIDS Commission in a report released last week said it plans to test and counsel 500,000 people for HIV annually by 2012 and provide opportunistic infection prevention and treatment services to 90% of HIV-positive people in the country, Uganda's New Vision reports.

The report -- released at a two-day workshop attended by officials and HIV/AIDS advocates in Fort Portal, Uganda -- says the commission aims to increase access to antiretroviral drugs to 90% of HIV-positive people who require treatment.

It also says HIV testing and counseling will be available at 107 hospitals and 160 health centers across the country. The strategies include increasing HIV testing and counseling.

There are about 1.1 million HIV-positive people in Uganda, and the number of cases is expected to increase to 1.8 million by 2012 "at the current rate of 135,000 new infections annually," the report says (Thawite, New Vision/AllAfrica.com, 1/25).

The commission also plans to improve services for people coinfected with HIV and tuberculosis, Xinhua News Agency reports (Xinhua News Agency, 1/25).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk